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Abstract
Type 2 diabetes has long been known as adult onset diabetes, but it is now becoming
more and more prevalent in childhood and adolescents. Our youth, who have type 2 diabetes, are
subjected to the risk factors of diabetes earlier in life. A few risk factors that accompany the
diagnosis of diabetes are cardiovascular disease, kidney disease, and retinopathy. It is very
important to treat type 2 diabetes and keep children and adolescents in good glycemic control.
This article seeks to review the most optimal initial treatment in youth diagnosed with type 2
diabetes by comparing Metformin to lifestyle modifications. In the youth population only two
pharmacological options are FDA approved in the United States; these being Metformin and
insulin. Metformin is the recommended initial therapy in youth with type 2 diabetes as long as
there is no ketoacidosis present. Lifestyle modifications have been the initial treatment in adults
for type 2 diabetes; with dietary changes and exercise, glycemic control has been achieved. This
literature review, reviewed ten different research articles involving treatment of type 2 diabetes
in youth. Metformin is the recommended initial therapy to use in the youth population. Lifestyle
modifications is used in conjunction with Metformin, but not as monotherapy. Several different
studies have found that lifestyle modification does not change glycemic control in youth. Several
different factors may contribute to this, such as, culture, peer pressure, high rates of depression,
and parenting. Two studies did show benefit in glycemic control following a very strict, very low
calorie diet, but more research needs to be done in this area before it can be recommended.
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Background
Diabetes is a concern across all populations and ethnicities due to the morbidity and
mortality that is related to it. Two types of diabetes that are commonly reported on are type 1 and
type 2 diabetes. To understand the difference, the CDC reported,
Type 2 diabetes usually begins as insulin resistance, a disorder in which cells,
primarily within the muscles, liver, and fat tissue, do not use insulin properly. Type 1
diabetes develops when the cells in the pancreas that produce insulin, known as beta
cells, are destroyed. The destruction of the beta cells limits the making and release of
insulin. (2014).
Type 2 diabetes is when the cells in the body start to fail to use the insulin the body is
producing and type 1 diabetes is when the body is unable to produce the insulin.
In the case report involving Dorthea, type 2 diabetes is being managed by medication and
lifestyle modification. Over the last 6 months her Hemoglobin (Hgb) A1C increased from 8.2
percent to 8.5 percent. While that may not seem like a significant increase, it definitely shows no
improvement and continues to put Dorthea at risk for the complications of diabetes and
hyperglycemia. In this case report, type 2 diabetes was managed by increasing her Metformin to
1500mg daily from 1000mg daily. She was changed to Metformin XR once daily from twice
daily Metformin. This was discussed with the patient with the intent to make it easier for her to
take the medication only once daily and to also decrease the likelihood of adverse drug effects as
we increased her dosage. “Gastrointestinal side effects are common with metformin which can
be minimized by taking the drug after meals, slow titration of doses or by use of extended release
preparations,” (Ramkumar & Tandon, 2012, p. S90).
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Type 2 diabetes has been around in the adult population for a long time and it is now
becoming more and more prevalent in childhood and adolescents. Karres et al. (2014) reported,
“In the U.S. one in three new cases of diabetes mellitus diagnosed in patients younger than 18
years of age is Type 2 Diabetes,” (p.2665). According to the 2014 Diabetes Report Card by the
Centers for Disease Control and Prevention,
More than 20,000 US youth younger than age 20 had type 2 diabetes in 2009, and
more than 5,000 new cases of type 2 diabetes are estimated to be diagnosed among US
youth younger than age 20 each year. Rates of new cases are higher among youth aged 10
to19 than among younger children. Rates of type 2 diabetes are higher among youth aged
10 to 19 in some racial and ethnic minority groups than among non-Hispanic whites.
(2015, p. 5).
The importance of prevention, early detection, and treatment are important in order to
maintain health and quality of life. Karres, et al. (2014) reported,
Diabetes complications in children and adolescents may be evident as early as 2
years after diagnosis. Data from the Treatment Options for type 2 Diabetes in
Adolescents and Youth (TODAY) study suggest almost half of children and adolescents
with Type 2 Diabetes in the U.S. have suboptimal glycemic control after four to five
years of treatment with metformin monotherapy and that hypertension, dyslipidemia, and
early microvascular complications (e.g., nephropathy and retinopathy) are highly
prevalent in these patients. (p. 2665).
There are guidelines for the treatment in type 2 diabetes in youth, but even with the
guidelines, it is stated that they are only guidelines and each case has to be monitored and treated
in the best interest of that person. The medications that the FDA have approved in the United
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States for the treatment of type 2 diabetes in the youth are Metformin and insulin. (Copeland et
al., 2013, p. 372). With that in mind a literature review was performed comparing the treatment
of type 2 diabetes in youth comparing Metformin versus lifestyle modifications.
Case Report
For the case report please refer to the appendix.
Literature
Literature Search
A literature search was performed using the Harley French Library of the University of
North Dakota. The databases that were used within the Harley French Library were CINAHL
and PubMed.
Using the PubMed database, the search terms used were “lifestyle modification and
treatment of diabetes in adolescents.” A filter of five years was placed and 20 articles fit the
criteria. Article titles were reviewed for relevance and four out of the 20 were articles pertaining
to the question. PubMed database was then searched using the terms “metformin and lifestyle in
the treatment of type 2 diabetes in adolescents.” A filter of full text, five years, and humans was
placed to fit the criteria. Article titles were reviewed and two out of 30 was relevant to the topic
and not a duplicate. After reviewing the reference pages one article was relevant and searched by
title in PubMed.
Using the CINAHL database the search terms used were “type 2 diabetes in adolescents
and metformin and lifestyle” which resulted in 14 articles with four articles being duplicates
from PubMed. Article titles were reviewed and three out of 14 were relevant to the topic and not
a duplicate.
Ten articles were found between PubMed and CINAHL databases. All ten articles were
available electronically through the Harley French Library of the University of North Dakota.
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Literature Review
A random control trial, RCT, called the TODAY study was performed comparing three
treatment regimens for type 2 diabetes in recently diagnosed adolescents and children. The
TODAY study stands for Treatment Options for Type 2 Diabetes in Adolescent and Youth. The
three treatment regimens were metformin alone; metformin with lifestyle modifications; and
metformin with a second pharmacologic agent, rosiglitazone. For the purpose of this literature
review the focus is comparing metformin and lifestyle modifications. This study looked at time
of treatment initiated to time of treatment failure. The TODAY study group followed participants
for 2 years and found that while lifestyle modification helped to reduce bodyweight this did not
correlate to increased glycemic control (2012, p. 2254). “Metformin combined with lifestyle
intervention was no better than metformin alone in maintaining glycemic control” (TODAY
study group, 2014, p.2253). The findings of this study support the use of Metformin in the youth
population for type 2 diabetes and that lifestyle modification made no difference to their
glycemic control.
Narasimhan and Weinstock (2014) reviewed lessons learned from the TODAY study.
The points from the TODAY study group mentioned previously were reiterated in this article
with some additional information. Lifestyle modification is one of the main treatments for type 2
diabetes in adults, but in this study it is not showing as effective in the youth population. The
question is, why is it not working or what are the differences among the youth population when
compared to adults? Narasimhan and Weinstock (2014) stated, “Hormonal changes in
adolescence coupled with varying physical and emotional factors, including family interactions,
peer influences, and poor socioeconomic conditions typically seen in youth-onset type 2 diabetes
and obesity, pose unique challenges, especially when promoting lifestyle change” (p. 807).
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Narasimhan and Weinstock (2014) also recommended that additional lifestyle studies should be
performed in order to find out what changes would be beneficial due to the findings of
Metformin with lifestyle modification having no further benefit than Metformin alone. They also
made the point, “Metformin monotherapy provided durable glycemic control in only half of the
participants, indicating that this disease can be more aggressive and rapidly progressive when
onset is early in life” (Narasimhan & Weinstock, 2014, p. 815). This point reiterates the
importance of prevention, detection, and treatment.
A retrospective study was performed by Harden, Cowan, Velasquez-Mieyer, and Patton
in 2007, looking at lifestyle intervention and metformin on weight management and metabolic
syndrome in obese adolescents. Metabolic syndrome was defined as, “Clustering of
hypertension, dyslipidemia, central obesity, hyperglycemia, and insulin resistance which leads to
an increased incidence of atherosclerotic cardiovascular disease in adulthood” (Cowan,
Velasquez-Mieyer, & Patton, 2007, p. 369). While this study did not look directly at type 2
diabetes, all of these symptoms in the metabolic syndrome are present prior to the onset of
diabetes (Cowan, Velasquez-Mieyer, & Patton, 2007, 374). The study results performed by
Cowan, Velasquez-Mieyer, and Patton’s were reported as,
Both lifestyle changes and metformin can produce weight loss, however
metformin significantly increased weight loss compared to just lifestyle modification
alone. The study also showed that those subjects without type 2 diabetes were more likely
to lose weight than those subjects who had type 2 diabetes (2007, p. 374).
The finding of this study show again how lifestyle modification alone in the treatment of
type 2 diabetes were not as effective as when used in conjunction with Metformin. The study
findings regarding, youth are more likely to lose weight when they don’t have type 2 diabetes
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compared to those that do, also supports the fact that lifestyle modification is not the main
treatment in youth.
A Quasi-experimental prepost study design was performed looking at the feasibility of an
intensive lifestyle intervention for youth with type 2 diabetes. The intervention in this study was,
“Sixteen weeks of peer-based support for achieving the following lifestyle goals of a seven to 10
percent reduction in body weight, 200 minutes of moderate to vigorous physical activity weekly,
reduced sugar-sweetened beverage intake, and increased fruit and vegetable intake” (Huynh et
Al., 2015, p. 485).
The results of this study show similar results to other studies involving youth with type 2
diabetes. Huynh et al. (2015) reported, “The intensive lifestyle intervention did not elicit a mean
change in cardiometabolic outcomes in youth with type 2 diabetes” (p.489). Huynh et al. (2015)
did report that the challenges with self-management of type 2 diabetes in the youth include,
“Perceptions of guilt and lack of control, additionally social and familial support is considered a
critical determinant of adopting healthy living behaviors at diagnosis and beyond” (p.489).
During this study the youth reported that noncompetitive group physical activity was the most
beneficial and acceptable to incorporate into daily life (Huynh et al., 2015). Lifestyle
modification is not recommended as monotherapy in youth with type 2 diabetes, because it is not
showing evidence that it improves diabetic outcomes. This study gave some insight as to maybe
why it doesn’t work, reporting on peer pressure, support systems, and the perceptions of the
youth regarding their diabetes.
There are a lot of factors that need to be considered when addressing lifestyle
modifications. Some of these factors include culture, household finances, and access to sport
facilities. A cohort study, performed by Turner et Al., was performed to look at educational and
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psychological issues in adolescents’ views and experiences with treatment of type 2 diabetes. In
regard to healthy diet choices one subject in the study related “I’m Muslim and we don’t really
think of healthy food” (Turner et al., 2015, p.252). This would be related to culture and not every
culture is taught to watch what kind of food they are eating or have the option to eat differently
than the family. Another participant in this study voiced that they had financial difficulty and
whatever food his parents could get is what they had on hand. (Turner et al., 2015, p.252). This
cohort study found that there was a high failure rate with lifestyle modification due to not
sustaining the practices. Some reasons were falling back into old eating habits, only exercising if
there was time, and reducing but not eliminating sugary foods and drinks (Turner et al., 2015,
p.252).
This cohort study also found that adolescents were not concerned about having diabetes.
They had assumed they would get the disease due to knowing other family members who also
have it. While there may by some hereditary tendency in acquiring the disease the adolescents do
not appear to know the seriousness of their diagnosis (Turner et al., 2014, p.252). Taking this
into account, it would be hard to get someone to adhere to strict and permanent lifestyle
modifications.
A systematic review was performed addressing the questions of, “Effectiveness of
treatment modalities for type 2 diabetes in children and adolescents and the efficacy of
pharmaceutical therapies for treatment of children and adolescents with type 2 diabetes”
(Copeland et al., 2013, p.368). One recommendation made according to Copeland et. Al, (2013)
is, “Patients who do not require insulin initially, lifestyle modifications of nutrition and exercise
need to be implemented along with metformin as first line therapy for children and adolescents at
the time of diagnosis” (p. 371). Copeland et al. go on to report,
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That expert consensus is that fewer than 10% of pediatric type 2 diabetes patients
will attain their blood glucose goals through lifestyle modification alone. The barriers
that are present among the child and adolescent population are high rates of depression in
teenagers and peer pressure to participate in activities that center around unhealthy
eating. (p. 371).
There is some speculation regarding the adolescent’s opinion on the seriousness of their
disease related to only having to take oral tablets instead of an injectable insulin. The
recommendation for the initial treatment of type 2 diabetes in youth is to, “Use metformin as
initial pharmacologic agent in adolescents presenting with mild hyperglycemia and without
ketonuria,” (Copeland et. al, 2013, p.372). Copeland et Al. (2013) reported,
The benefits of Metformin use are potential weight loss, lower risk of
hypoglycemia, improves insulin sensitivity and normalize menstrual cycles in females
with polycystic ovary syndrome, taking pills is more comfortable than injections, less
instruction time is required to start the medication, and adolescents often don’t accept
having to take injections.
There are viewpoints out there that report barriers of taking Metformin as initial therapy
for type 2 diabetes in the youth. “One thought is that adolescents on Metformin don’t realize how
serious their disease is, because they are not on insulin. In adolescents, the use of insulin may
convey the seriousness of the disease and also lead to better follow-up” (Copeland, et al., p. 372).
Education on the seriousness of diabetes needs to be continually provided to youth, as well as,
education on the importance of the treatment plan being followed.
Along with the initial use of metformin the recommendation is to incorporate a healthy
diet along with exercise. This study supports the use of Metformin for the treatment of type 2
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diabetes in youth in conjunction with lifestyle modifications and not using lifestyle modification
as a mono-therapy. Copeland et al. reported,
The recommendation is 60 minutes of moderate to vigorous exercise daily with
less than 2 hours of screen time unless related to work or school. The diet
recommendation from the Academy of Nutrition and Dietetics is a well balanced, 900 to
1200 kcal per day, diet for children six to 12 years of age and no less than 1200 kcal per
day in adolescents 13 to 18 years of age of a well balance diet. (2013, p. 376).
A literature review performed by McGavock, Dart, and Wicklow was done to promote
lifestyle therapy for the treatment of type 2 diabetes in the youth. This literature review looked at
benefits of lifestyle modifications in obese youth compared to obese youth with type 2 diabetes.
The conclusion of this review found, lifestyle interventions in obese youth improved measures of
adiposity and cardiometabolic risk. The more intense the intervention the better the outcome.
Unfortunately, the evidence reviewed does not support the use of lifestyle modification in obese
youth with type 2 diabetes as a therapy to be used alone (McGavock, Dart, and Wicklow, 2015,
p. 568). McGavock, Dart, and Wicklow (2015) reported, the reasons for failure of lifestyle
modification in youth are “Youth with type 2 diabetes experience more significant and rapid
declines in beta cell function and suffer from disproportionately higher levels of mental problems
and social adversity” (p.568).
In regards to lifestyle modification the focus is often on exercise and diet. One ancillary
study that was done was on parenting style and youth conflict related to medication adherence in
youth with type 2 diabetes. The study participants for this ancillary study were part of the RCT
TODAY study. In this ancillary study the parenting styles of authoritarian, authoritative, and
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permissive were studied to see if there was any change to medication adherence in the youth with
type 2 diabetes.
The criteria for this study, according to Saletsky, Trief, Anderson, Rosenbaum, and
Weinstock (2014) were, “Youth with type 2 diabetes less than 2 years in duration, ages ten to 17
years old, and treatment was metformin with intensive lifestyle change intervention” (p.177).
The study collected data at baseline, six months, and 12 months. The conclusion of the study
found, “Parenting style, as reported by youth with type 2 diabetes, was a significant predictor of
medication adherence. Youth that perceived parents as supporting greater autonomy toward selfcare behaviors toward daily tasks and less of an authoritarian style toward diabetes tasks,
predicted better future medication adherence” (Saletsky, Trief, Anderson, Rosenbaum, &
Weinstock, 2014, p.182-183). It is important to monitor medication, diet, and activity when used
as treatment for type 2 diabetes in the youth. This study shows us that it may also be important to
talk about parent and youth relationship, as this lifestyle modification could affect adherence to
treatment.
A pilot study done in 2016, looked at the reversal of type 2 diabetes in adolescent if
adherence to a very-low-energy diet was maintained. The intervention in the study was the verylow-energy diet, VLED. According to Gow, Baur, Johnson, Cowell, and Garnett, (2016),
For the first eight weeks participants consumed four meal replacements daily or
three meal replacements and one meal. The diet was approximately 800 kcal/day.
Additional energy-free foods could be consumed and at least 2 liters of water or other
energy-free drink was encouraged. Participants were weaned to a reduced-energy diet
between weeks nine and twelve by dropping one meal replacement at a time. The
reduced-energy diet was followed up to 34 weeks (p.407).
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The findings of this study showed reversal of type 2 diabetes in some youth. The
participants in the study were either on metformin or insulin when the study started. Those on
insulin eventually stopped using insulin, but the metformin participants were able to stay on the
medication without adverse effects. Gow et al. (2016) reported, “This is the first prospective
study in youth that demonstrates a VLED is an acceptable and feasible option for youth with type
2 diabetes and that adherence can lead to reversal of type 2 diabetes as seen in adult studies”
(p.411). This study was small and additional studies will need to be done, but it does show the
possibility of a short-term VLED being used a first-line therapy in youths.
In 2004, a controlled trial was done on the treatment of type 2 diabetes in childhood using
a very-low calorie diet (VLCD). Willi, Martin, Datko, and Bran (2004) reported,
The diet consisted of high-protein, low-fat, low-carbohydrate, between 680 and
800 calories in simple foods containing 80-110 g protein and less than 30 g each of
carbohydrate and fat. Subjects consumed 13 oz. of lean meats, three cups of low-calorie
vegetables, and additional low-calorie foods containing NutraSweet. Because this diet is
not nutritionally complete vitamins and minerals were supplemented (p.349).
The study findings showed that the VLCD decreased dependence on antidiabetic medications,
improved Hgb A1C and blood glucose levels, improved blood pressures, and increased weight
loss. According to this study, the use of lifestyle modifications can be used as an initial treatment
for type 2 diabetes in youth as long as it is intense and strictly followed (Willi, Martin, Datko, &
Bran, 2004, p. 352).
Learning Points
In conclusion, learning points from this literature review are listed and summarized below.
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Metformin is the initial treatment used in the management of type 2 diabetes in youth, as
long as there is no ketoacidosis evident.

•

The recommendation for initial therapy in youth with type 2 diabetes is metformin in
conjunction with lifestyle modifications. The evidence doesn’t necessarily support
lifestyle modifications improving the diabetes, but lifestyle modifications can help
decrease cardiometabolic risk factors and decrease body weight.

•

While lifestyle modification is one of the main treatments in adults with type 2 diabetes,
lifestyle modification in the youth should not be used as a mono-therapy due to evidence
showing no improvement in diabetes control.

•

There is some evidence that a very strict, very low calorie diet can reverse type 2 diabetes
in youth. In order to maintain this there needs to be family and peer support as well as
supervision while on this diet. The treatment is intense and very rigid. More research is
needed to support this as a treatment strategy

•

In the youth population there is a high failure rate with lifestyle modifications due to
multiple factors including, peer pressure, culture, depression, and not grasping the
magnitude and seriousness of diabetes.
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Appendix
Case Report
Chief Complaint: Dorthea is a 60y/o Caucasian female presenting today for diabetes follow-up.
She saw diabetes education last week and was encouraged to come in for a follow-up.
HPI: Patient presents today for follow-up on Type 2 Diabetes. Her last Hgb A1C 3 months ago
was 8.2%. She checks her blood sugars twice weekly and on average her blood sugars are
running 150 to 200. She relates she gets exercise throughout the week by walking a couple miles,
3 to 4 times/ weekly. She also relates she is compliant with her prescriptions medications. Her
diet does consist of a lot of fried foods and sweet foods.
She is concerned today because she has been tired over the last couple months. As stated above,
she does get exercise 3 to 4 times/weekly. She reports sleeping 7 to 8 hours at night and her diet
consists a lot of fried and sweet foods. Denies needing to take naps.
Past Medical History:
•

Diabetes Mellitus Type 2

•

Hypercholesteremia

•

Hypertension

Past Surgical History:
•

Not on file

Social History:
•

Denies tobacco use

•

Occasionally alcohol use

•

Denies drug use
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Family History:
•

Mother is deceased and had a history of diabetes

•

Father is deceased and had a history of leukemia, colon cancer, prostate cancer, and heart
disease

Allergies:
•

Penicillin (rash)

Prior to Arrival Medications:
•

Metformin 500mg twice daily

•

Aspirin 81mg daily

•

Lisinopril 20mg daily

•

Atorvastatin 20mg daily

•

Multivitamin daily

Review of Systems:
Constitutional: Positive for fatigue (See HPI). Negative for activity change, chills, fever and
unexpected weight change.
HENT: Negative for congestion, ear pain, rhinorrhea, sinus pressure and sore throat.
Eyes: Negative for pain, discharge, redness, itching and visual disturbance.
Does see Ophthalmology yearly, last seen in May 2016.
Respiratory: Negative for cough, chest tightness, shortness of breath and wheezing.
Cardiovascular: Negative for chest pain, palpitations and leg swelling.
Gastrointestinal: Negative for abdominal pain, constipation, diarrhea, nausea and vomiting.
Endocrine: Negative for polydipsia, polyphagia and polyuria.
Genitourinary: Negative for dysuria, frequency, urgency, vaginal discharge and vaginal pain.
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Musculoskeletal: Negative for arthralgias and myalgias.
Skin: Negative for rash and wound.
Neurological: Negative for dizziness, light-headedness and headaches.
Psychiatric/Behavioral: Negative for sleep disturbance and suicidal ideas. The patient is not
nervous/anxious.

Physical Exam:
Vitals this visit: Bp 148/98, Pulse 80, Temp 98.6F (37C), Resp 20
Constitutional: She is oriented to person, place, and time. She appears well-developed and wellnourished.
HENT:
Head: Normocephalic and atraumatic.
Right Ear: Tympanic membrane and external ear normal.
Left Ear: Tympanic membrane and external ear normal.
Mouth/Throat: Oropharynx is clear and moist. No oropharyngeal exudate.
Eyes: Conjunctivae are normal. Pupils are equal, round, and reactive to light. Right eye exhibits
no discharge. Left eye exhibits no discharge.
Fundoscopic exam:
The right eye shows no arteriolar narrowing. The right eye shows red reflex.
The left eye shows no arteriolar narrowing. The left eye shows red reflex.
Neck: No JVD present. No thyromegaly present.
Cardiovascular: Normal rate, regular rhythm and normal heart sounds. Exam reveals no gallop
and no friction rub.
No murmur heard.

METFORMIN VERSUS LIFESTYLE MODIFICATION

21

Pulmonary/Chest: Effort normal and breath sounds normal. No respiratory distress. She has no
wheezes. She has no rales.
Abdominal: Soft. Bowel sounds are normal. She exhibits no distension. There is no tenderness.
Musculoskeletal: She exhibits no edema.
Lymphadenopathy:
She has no cervical adenopathy.
Neurological: She is alert and oriented to person, place, and time.
Monofilament test performed bilaterally and all points on exam identified by patient.
Skin: Skin is warm, dry and intact.
Psychiatric: Her mood appears not anxious. She does not exhibit a depressed mood. She
expresses no suicidal ideation.
Orders Placed this Encounter:
•

TSH

•

CMP

•

Lipid Panel

•

CBC with Automated Differential

•

AMB Referral to Dietician

•

metformin (GLUCOPHAGE-XR) 750mg XR tablet- take two tabs by mouth daily (with
breakfast) disp: 30 tabs refills:11

Assessment:
•

Controlled type 2 diabetes mellitus E11.21

•

Hypercholesteremia E78.00

•

Essential Hypertension I10
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Malaise and fatigue R53.81

Plan:
Last Hgb A1C was 8.2, 6 months ago, and today Hgb A1C is 8.5. Increase the dosage of
Metformin 1500mg/day. Metformin is being changed to Metformin XL so that is it taken only
once daily to decrease the likelihood of adverse effects as we increase the dosage.
Due to Hgb A1C and lipid panel results a dietician referral was placed for lifestyle modification
for type 2 diabetes and elevated cholesterol. Hgb A1C 8.5, total cholesterol 209, triglycerides
184, Direct HDLC 31, and LDL 95.
I have encouraged patient to remain active and continue walking 3 to 4 times daily. Encouraged
her to increase her activity.
CMP results within normal limits.
I will notify her by mail of her TSH and CBC results or I will contact her by phone if any
concerns.
Education provided on daily foot exams and yearly eye exams.
Return to clinic in 4 weeks for recheck regarding the increased dose of Metformin to see how she
is feeling.
Follow-up in clinic in 3 months to recheck Hgb A1C and lipid panel.

